For endometrial cancer, we estimated a positive indirect effect through estradiol (RR 1.24; 95%CI, 1.03–1.65), and a stronger indirect effect through fasting insulin (RR 1.42; 95%CI, 0.96–2.26). Here, INS is linked to endometrial cancer.